Targeting mitochondrial apoptosis to overcome treatment resistance in cancer

بواسطة Ngoi N.Y.L., Choong C., Lee J., Bellot G., Wong A.L.A., Goh B.C., Pervaiz S.
منشور في 2020

Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: Study protocol of a randomised controlled trial to evaluate the effect of short messag...

بواسطة He Y., Tan E.H., Wong A.L.A., Tan C.C., Wong P., Lee S.C., Tai B.C.
منشور في 2019

Targeting metabolism in cancer cells and the tumour microenvironment for cancer therapy

بواسطة Li, J., Eu, J.Q., Kong, L.R., Wang, L., Lim, Y.C., Goh, B.C., Wong, A.L.A.
منشور في 2021

Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients

بواسطة Wong, A.L.-A., Yap, H.-L., Yeo, W.-L., Soong, R., Ng, S.-S., Wang, L.-Z., Cordero, M.T., Yong, W.-P., Goh, B.-C., Lee, S.-C.
منشور في 2014

Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometry

بواسطة Wang, L.-Z., Ong, R.Y.-L., Chin, T.-M., Thuya, W.-L., Wan, S.-C., Wong, A.L.A., Chan, S.-Y., Ho, P.C., Goh, B.-C.
منشور في 2014

Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models

بواسطة Syn N.L., Lim P.L., Kong L.R., Wang L., Wong A.L.-A., Lim C.M., Loh T.K.S., Siemeister G., Goh B.C., Hsieh W.-S.
منشور في 2019

A review on liquid chromatography-tandem mass spectrometry methods for rapid quantification of oncology drugs

بواسطة Wong, A.L.-A, Xiang, X, Ong, P.S, Mitchell, E.Q.Y, Syn, N, Wee, I, Kumar, A.P, Yong, W.P, Sethi, G, Goh, B.C, Ho, P.C.-L, Wang, L
منشور في 2020

Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: A randomised controlled trial to evaluate the effect of short message service (SMS) re...

بواسطة Tan, E.H., Wong, A.L.A., Tan, C.C., Wong, P., Tan, S.H., Ang, L.E.Y., Lim, S.E., Chong, W.Q., Ho, J., Lee, S.C., Tai, B.C.
منشور في 2021

A sensitive liquid chromatography-tandem mass spectrometry method for the determination of nimbolide in mouse serum: Application to a preclinical pharmacokinetics study

بواسطة Wang, L, Khoa Phan, D.-D, Syn, N, Xiang, X, Song, H, Thuya, W.L, Yang, S, Wong, A.L.-A, Kumar, A.P, Yong, W.P, Sethi, G, Ho, P.C.-L, Goh, B.C
منشور في 2020

Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development

بواسطة Wang, L, Khoa Phan, D.D, Zhang, J, Ong, P.-S, Thuya, W.L, Soo, R.A, Wong, A.L.-A, Yong, W.P, Lee, S.C, Ho, P.C.-L, Sethi, G, Goh, B.C
منشور في 2020

Pharmacogenetics-Guided Phase i Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid Tumours

بواسطة Soo, R.A, Syn, N, Lee, S.-C, Wang, L, Lim, X.-Y, Loh, M, Tan, S.-H, Zee, Y.-K, Wong, A.L.-A, Chuah, B, Chan, D, Lim, S.-E, Goh, B.-C, Soong, R, Yong, W.-P
منشور في 2020

Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1

بواسطة Wang, L, Chan, C.E.L, Wong, A.L.-A, Wong, F.C, Lim, S.W, Chinnathambi, A, Alharbi, S.A, Lee, L.S.-U, Soo, R, Yong, W.P, Lee, S.C, Ho, P.C.-L, Sethi, G, Goh, B.C
منشور في 2020

Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients

بواسطة Wang, L.-Z., Ramírez, J., Yeo, W., Chan, M.-Y.M., Thuya, W.-L., Lau, J.-Y.A., Wan, S.-C., Wong, A.L.-A., Zee, Y.-K., Lim, R., Lee, S.-C., Ho, P.C., Lee, H.-S., Chan, A., Ansher, S., Ratain, M.J., Goh, B.-C.
منشور في 2014

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: A randomized controlled trial

بواسطة Syn N.L., Wong A.L.-A., Lee S.-C., Teoh H.-L., Yip J.W.L., Seet R.C.S., Yeo W.T., Kristanto W., Bee P.-C., Poon L.M., Marban P., Wu T.S., Winther M.D., Brunham L.R., Soong R., Tai B.-C., Goh B.-C.
منشور في 2019

Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib

بواسطة Wong A.L.A., Lim J.S.J., Sinha A., Gopinathan A., Lim R., Tan C.-S., Soh T., Venkatesh S., Titin C., Sapari N.S., Lee S.-C., Yong W.-P., Tan D.S.P., Pang B., Wang T.-T., Zee Y.-K., Soong R., Trnkova Z., Lathia C., Thiery J.-P., Wilhelm S., Jeffers M., Goh B.-C.
منشور في 2018

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer

بواسطة Wong A.L.A., Sundar R., Wang T.-T., Ng T.-C., Zhang B., Tan S.-H., Soh T.I.P., Pang A.S.L., Tan C.-S., Ow S.G.W., Wang L., Mogro J., Ho J., Jeyasekharan A.D., Huang Y., Thng C.-H., Chan C.-W., Hartman M., Iau P., Buhari S.A., Goh B.-C., Lee S.-C.
منشور في 2020